178 related articles for article (PubMed ID: 37978447)
21. Prognostic significance of osteopontin in hepatocellular carcinoma: a meta-analysis.
Zhang CH; Xu GL; Jia WD; Ge YS; Li JS; Ma JL; Ren WH
Int J Cancer; 2012 Jun; 130(11):2685-92. PubMed ID: 21780114
[TBL] [Abstract][Full Text] [Related]
22. Prognostic significance of cyclin-dependent kinase subunit 2 (CKS2) in malignant tumours: a meta-analysis and bioinformatic analysis.
Zhang Y; Li Z; Huang Y; Zou B; Xu Y
BMJ Open; 2024 Jan; 14(1):e073887. PubMed ID: 38296306
[TBL] [Abstract][Full Text] [Related]
23. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
24. Meta-Analysis of the Prognostic and Clinical Value of Tumor-Associated Macrophages in Hepatocellular Carcinoma.
Zhang J; Chang L; Zhang X; Zhou Z; Gao Y
J Invest Surg; 2021 Mar; 34(3):297-306. PubMed ID: 31412745
[No Abstract] [Full Text] [Related]
25. Prognostic value of cytokeratin 19 in hepatocellular carcinoma: A meta-analysis.
Sun DW; Zhang YY; Sun XD; Chen YG; Qiu W; Ji M; Lv GY
Clin Chim Acta; 2015 Aug; 448():161-9. PubMed ID: 26164382
[TBL] [Abstract][Full Text] [Related]
26. Significant association between high neutrophil-lymphocyte ratio and poor prognosis in patients with hepatocellular carcinoma: a systematic review and meta-analysis.
Xu C; Wu F; Du L; Dong Y; Lin S
Front Immunol; 2023; 14():1211399. PubMed ID: 37809083
[TBL] [Abstract][Full Text] [Related]
27. Prognostic value of platelet to lymphocyte ratio in hepatocellular carcinoma: a meta-analysis.
Ma W; Zhang P; Qi J; Gu L; Zang M; Yao H; Shi X; Wang C; Jiang Y
Sci Rep; 2016 Oct; 6():35378. PubMed ID: 27739490
[TBL] [Abstract][Full Text] [Related]
28. Prognostic significance of glypican-3 expression in hepatocellular carcinoma: A meta-analysis.
Liu H; Yang C; Lu W; Zeng Y
Medicine (Baltimore); 2018 Jan; 97(4):e9702. PubMed ID: 29369198
[TBL] [Abstract][Full Text] [Related]
29. Overexpression of glypican-3 is a predictor of poor prognosis in hepatocellular carcinoma: An updated meta-analysis.
Zhang J; Zhang M; Ma H; Song X; He L; Ye X; Li X
Medicine (Baltimore); 2018 Jun; 97(24):e11130. PubMed ID: 29901640
[TBL] [Abstract][Full Text] [Related]
30. Hepatic resection alone versus in combination with pre- and post-operative transarterial chemoembolization for the treatment of hepatocellular carcinoma: A systematic review and meta-analysis.
Qi X; Liu L; Wang D; Li H; Su C; Guo X
Oncotarget; 2015 Nov; 6(34):36838-59. PubMed ID: 26451613
[TBL] [Abstract][Full Text] [Related]
31. Management of people with early- or very early-stage hepatocellular carcinoma: an attempted network meta-analysis.
Majumdar A; Roccarina D; Thorburn D; Davidson BR; Tsochatzis E; Gurusamy KS
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD011650. PubMed ID: 28351116
[TBL] [Abstract][Full Text] [Related]
32. The Prognostic Significance of miR-21 Expression among Surgically Resected Hepatocellular Carcinoma Patients: Evidence from a Meta-Analysis and Retrospective Cohort Study.
Huang X; Xiong Y; Yang J; Yang G; Li J
Biomed Res Int; 2020; 2020():8848158. PubMed ID: 33415165
[TBL] [Abstract][Full Text] [Related]
33. The prognostic significance of long non-coding RNAs in hepatocellular carcinoma: An updated meta-analysis.
Liu J; Wei Y; Wang T; Zhang Z; Huang H; Wang C; Li H; Jia Q; Wu H; Zou T
Int J Biol Markers; 2020 Dec; 35(4):3-11. PubMed ID: 33208027
[TBL] [Abstract][Full Text] [Related]
34. Circulating Tumor Cells for Predicting the Prognostic of Patients with Hepatocellular Carcinoma: A Meta Analysis.
Fan JL; Yang YF; Yuan CH; Chen H; Wang FB
Cell Physiol Biochem; 2015; 37(2):629-40. PubMed ID: 26344495
[TBL] [Abstract][Full Text] [Related]
35. The diagnostic value of the combination of Golgi protein 73, glypican-3 and alpha-fetoprotein in hepatocellular carcinoma: a diagnostic meta-analysis.
Zhao S; Long M; Zhang X; Lei S; Dou W; Hu J; Du X; Liu L
Ann Transl Med; 2020 Apr; 8(8):536. PubMed ID: 32411759
[TBL] [Abstract][Full Text] [Related]
36. Prognostic value of osteopontin in patients with hepatocellular carcinoma: A systematic review and meta-analysis.
Sun T; Li P; Sun D; Bu Q; Li G
Medicine (Baltimore); 2018 Oct; 97(43):e12954. PubMed ID: 30412113
[TBL] [Abstract][Full Text] [Related]
37. Clinicopathologic and prognostic significance of tumor-infiltrating CD8+ T cells in patients with hepatocellular carcinoma: A meta-analysis.
Xu X; Tan Y; Qian Y; Xue W; Wang Y; Du J; Jin L; Ding W
Medicine (Baltimore); 2019 Jan; 98(2):e13923. PubMed ID: 30633166
[TBL] [Abstract][Full Text] [Related]
38. Investigation of the value of miR-21 in the diagnosis of early stage HCC and its prognosis: a meta-analysis.
Yan SR; Liu ZJ; Yu S; Bao YX
Genet Mol Res; 2015 Sep; 14(3):11573-86. PubMed ID: 26436398
[TBL] [Abstract][Full Text] [Related]
39. Sarcopenia Predicts Prognosis of Patients Undergoing Liver Resection for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.
Zhang H; Zhang L; Wang Y; Zou J; Zhang T
Nutr Cancer; 2023; 75(3):776-784. PubMed ID: 36537813
[TBL] [Abstract][Full Text] [Related]
40. The prognostic significance of preoperative neutrophil-lymphocyte ratio in patients with hepatocellular carcinoma receiving hepatectomy: A systematic review and meta-analysis.
Wang Y; Peng C; Cheng Z; Wang X; Wu L; Li J; Huang C; Guo Q; Cai H
Int J Surg; 2018 Jul; 55():73-80. PubMed ID: 29787804
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]